Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of… May 18, 2021
Economic Burden Of Major Depressive Disorder Is $326.2 Billion Annually, According To New Study May 5, 2021